Ozempic is displayed in a pharmacy in Provo

BY Reuters • November 9, 2023

A pharmacist displays a box of Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes made by Lilly at Rock Canyon Pharmacy in Provo, Utah, U.S. March 29, 2023. REUTERS/George Frey/File Photo

« Eli Lilly is still seeking UK approval on pen for weight-loss drug